Quick answer: Peptide Sciences, a major US research peptide vendor, ceased operations on March 6, 2026, due to increasing regulatory pressure, quality control issues with products like retatrutide, and restrictions from financial service providers.
On March 6, 2026, Peptide Sciences, the largest research peptide vendor in the United States, abruptly ceased operations. This unexpected shutdown left many researchers and laboratories uncertain about pending orders and peptide sourcing. This article details the history of Peptide Sciences, the regulatory and market factors behind its closure, and guidance on identifying reliable peptide suppliers in the current research landscape.
Peptide Sciences: A Leading Name Among Peptide Hackers
Peptide Sciences was a prominent supplier for over 30 years, serving the research peptide community including peptide hackers in Los Angeles and beyond. Founded in 1990 and based in Henderson, Nevada, the company specialized in custom peptide synthesis using solid-phase methods, offering peptides, proteins, and amino acid derivatives with claimed purities above 99%, supported by Certificates of Analysis (COA) and batch documentation. This transparency was a key factor in its widespread use among researchers who value verified purity and reproducibility.
The company’s extensive catalog and consolidated ordering process established it as a default vendor for many in the peptide research community. Peptide Sciences’ reputation was built on a combination of longevity, product range, and accessible documentation, which collectively fostered trust among peptide hackers and research institutions.
When Did Peptide Sciences Shut Down?
Peptide Sciences officially announced its shutdown on March 6, 2026. The company posted a brief notice confirming the voluntary closure and immediately halted all order processing. No detailed explanation or refund procedures were provided, leaving many researchers with unfulfilled orders and no recourse. The website went offline shortly after, ceasing all customer communications and order functions. This shutdown marked the end of what had been the largest US-based research peptide vendor.
What Led to the Peptide Sciences Shutdown in 2026?
The closure was influenced by multiple converging factors:
- Regulatory Enforcement: Increasing FDA scrutiny and enforcement actions against peptide vendors intensified throughout 2024 and 2025. Warning letters targeted unapproved marketing of peptides such as semaglutide and tirzepatide. Trade rulings restricted importation of infringing peptides, and federal raids shuttered warehouses of major suppliers. New legislation in early 2026 aimed to explicitly ban sales of research chemicals biologically identical to approved drugs.
- Quality Control Concerns: Public reports revealed retatrutide samples from Peptide Sciences failed multiple purity tests, including detection of counterfeit products. Such findings undermined confidence in product reliability.
- Financial Service Restrictions: Payment processors increasingly categorized peptide sales as high-risk, cutting off vendors’ access to traditional financial services.
These pressures combined to create an unsustainable environment for Peptide Sciences’ mail-order business model.
Peptide Sciences Website Status in 2026
Following the shutdown announcement, the Peptide Sciences website ceased functioning as an order platform and went offline. This eliminated the primary channel for product information, batch documentation access, and customer support. The absence of a physical storefront or direct customer service compounded the impact of this closure on peptide hackers and research institutions relying on the company.
How Large Was Peptide Sciences Before Closing?
Prior to shutdown, Peptide Sciences operated at a significant scale. Reports show the company generated approximately $7.4 million in online sales in December 2025 alone, offering a broad product range including peptide blends, IGF-1 proteins, melanotan peptides, cosmetic peptides, and capsules. The business provided flat-rate domestic shipping, free shipping above certain order amounts, and accepted diverse payment methods such as Apple Cash, Cash App, Zelle, Bitcoin, Ethereum, and credit cards.
Retatrutide for Sale: Quality and Availability Post-Shutdown
Retatrutide, a peptide of increasing interest in research, was among the products affected by the shutdown. Multiple batches sourced from Peptide Sciences failed purity validation, raising concerns about counterfeit or substandard products in circulation. Researchers seeking retatrutide or similar peptides should prioritize vendors providing verified batch COAs with HPLC and mass spectrometry data to ensure research integrity.
What the Peptide Sciences Shutdown Means for Peptide Hackers
The sudden loss of Peptide Sciences disrupted peptide sourcing for many research groups and peptide hackers. This event highlights the risks of relying solely on online-only vendors without physical presence or transparent quality assurance. It has prompted the community to reassess vendor selection criteria, focusing on accountability, documentation, and regulatory compliance.
Where to Buy Research Peptides Now: Vetting Reliable Vendors
In the aftermath of the Peptide Sciences shutdown, peptide hackers and researchers are advised to evaluate suppliers carefully. Key criteria include:
- Accessible Certificates of Analysis: Vendors should provide batch-specific COAs with detailed HPLC purity and mass spectrometry data publicly or upon request.
- Established Industry Track Record: Preference should be given to companies with verifiable operational history and consistent customer feedback.
- Secure and Transparent Payment Methods: Avoid vendors requiring prepaid, non-refundable orders without guarantees. Escrow or verified payment platforms offer better security.
- Physical Presence and Customer Support: Vendors with physical offices or storefronts and clear customer service contacts provide greater accountability.
Frequently Asked Questions
When Did Peptide Sciences Shut Down?
Peptide Sciences ceased operations on March 6, 2026, announcing a voluntary shutdown without prior notice.
Is Peptide Sciences Still in Business?
As of mid-2026, Peptide Sciences is no longer operational and does not fulfill orders or provide customer support.
What Was the Reason for Peptide Sciences’ Shutdown in 2026?
The shutdown resulted from increased regulatory enforcement, quality control failures including retatrutide batch inconsistencies, and financial service restrictions affecting peptide vendors.
What Was the Status of the Peptide Sciences Website in 2026?
The website went offline following the shutdown announcement, stopping all order processing and customer communications.
How Can Researchers Verify Peptide Purity Now?
Researchers should obtain batch-specific Certificates of Analysis featuring HPLC and mass spectrometry data before purchasing peptides to confirm quality.
Is Retatrutide Still Available for Research?
Retatrutide remains available from some peptide vendors; however, researchers must verify batch documentation rigorously due to past purity and counterfeit concerns.
This overview underscores the importance of rigorous vendor evaluation and transparent quality documentation in the evolving research peptide market. The Peptide Sciences shutdown serves as a cautionary example for peptide hackers and researchers sourcing peptides in a complex regulatory environment.
Further Reading and Vendor Verification Resources for Peptide Hackers
- How to Verify a Research Peptide Vendor in 2026 (COA, HPLC, and Track Record)
- Stranded by Peptide Sciences? A Checklist for Choosing Your Next Vendor
- Why a Physical Storefront Matters After Peptide Sciences Disappeared
These resources provide detailed guidance on evaluating peptide vendors, emphasizing the importance of transparent batch documentation and reliable customer service for peptide hackers.
Research Use Only
This article is provided for educational purposes. All peptides discussed are sold for research use only and are not intended for human consumption or therapeutic use.